Pembrolizumab-induced pneumonitis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pembrolizumab-induced pneumonitis

Published:2017-04 Issue:2 Volume:3 Page:00081-2016
ISSN:2312-0541
Container-title:ERJ Open Research
language:en
Short-container-title:ERJ Open Res

Author:

Leroy Vincent,Templier Carole,Faivre Jean-Baptiste,Scherpereel Arnaud,Fournier Clement,Mortier Laurent,Wemeau-Stervinou Lidwine

Publisher

European Respiratory Society (ERS)

Subject

Pulmonary and Respiratory Medicine

Reference17 articles.

1. PD-1 blockade induces responses by inhibiting adaptive immune resistance

2. Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer

3. Pembrolizumab versus Ipilimumab in Advanced Melanoma

4. Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial

5. Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhaled delivery of immunotherapy for treatment of lung cancer;Nanomedicine in Cancer Immunotherapy;2024

2. Lung erosion following adjuvant immunotherapy with pembrolizumab: a case report;Journal of Medical Case Reports;2023-10-07

3. PNEUMONITIS UNMASKED: AN ATYPICAL IMMUNE-RELATED ADVERSE EVENT FOLLOWING IMMUNE CHECKPOINT INHIBITOR THERAPY IN A STAGE IV BREAST CANCER PATIENT;CHEST;2023-10

4. PNEUMONITIS: IS IT PEMBROLIZUMAB OR COVID-19?;CHEST;2023-10

5. Radiological assessment of immunotherapy effects and immune checkpoint‐related pneumonitis for lung cancer;Journal of Cellular and Molecular Medicine;2023-07-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3